ImmunoGen, Inc. is a company in the U.S. stock market and it is a holding in 41 U.S.-traded ETFs. IMGN has around 17.7M shares in the U.S. ETF market. The largest ETF holder of IMGN is the SPDR S&P Biotech ETF (XBI), with approximately 5.62M shares. Investors may also find of interest that the ETF with the largest allocation to IMGN stock is Invesco Dynamic Biotechnology & Genome ETF (PBE), with a portfolio weight of 2.58%. On average, U.S. ETFs allocate 0.16% of IMGN to their portfolios.
Additionally, IMGN is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with IMGN as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 48.93%.